Page last updated: 2024-09-05

sb 203580 and albuterol

sb 203580 has been researched along with albuterol in 2 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (albuterol)	Trials (albuterol)	Recent Studies (post-2010) (albuterol)
3,489	4	1,137	10,108	3,059	2,058

Protein Interaction Comparison

Protein	Taxonomy	sb 203580 (IC50)	albuterol (IC50)
Beta-2 adrenergic receptor	Homo sapiens (human)		1.2618

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H	1
Gibbs, BF; Grabbe, J; Plath, KE; Wolff, HH	1

Other Studies

2 other study(ies) available for sb 203580 and albuterol

Article	Year
Identifying off-target effects and hidden phenotypes of drugs in human cells. Nature chemical biology, 2006, Volume: 2, Issue:6 Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship	2006
Regulation of mediator secretion in human basophils by p38 mitogen-activated protein kinase: phosphorylation is sensitive to the effects of phosphatidylinositol 3-kinase inhibitors and calcium mobilization. Journal of leukocyte biology, 2002, Volume: 72, Issue:2 Topics: Albuterol; Basophils; Calcimycin; Calcium Channel Blockers; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Chromones; Cyclic AMP; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Histamine Release; Humans; Imidazoles; Immunoglobulin E; Interleukin-13; Interleukin-4; Interleukins; Leukotriene C4; MAP Kinase Kinase 3; MAP Kinase Kinase 6; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Morpholines; N-Formylmethionine Leucyl-Phenylalanine; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pyridines; Salmeterol Xinafoate; Second Messenger Systems; Theophylline	2002

Article

Year

Identifying off-target effects and hidden phenotypes of drugs in human cells.

Nature chemical biology, 2006, Volume: 2, Issue:6

Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006

Regulation of mediator secretion in human basophils by p38 mitogen-activated protein kinase: phosphorylation is sensitive to the effects of phosphatidylinositol 3-kinase inhibitors and calcium mobilization.

Journal of leukocyte biology, 2002, Volume: 72, Issue:2

Topics: Albuterol; Basophils; Calcimycin; Calcium Channel Blockers; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Chromones; Cyclic AMP; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Histamine Release; Humans; Imidazoles; Immunoglobulin E; Interleukin-13; Interleukin-4; Interleukins; Leukotriene C4; MAP Kinase Kinase 3; MAP Kinase Kinase 6; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Morpholines; N-Formylmethionine Leucyl-Phenylalanine; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pyridines; Salmeterol Xinafoate; Second Messenger Systems; Theophylline

2002